Could lung transplantation have a role in stage IV NSCLC?
Lung transplantation may offer a potential treatment option for a highly selected group of patients…
Author ONA Webmaster
ONA Webmaster
Creating outstanding digital resources tailored for the Australian Oncology community, including independent news and a dedicated job portal.
ESMO GI 2026: EMERALD trials paint mixed picture for TACE-immunotherapy combinations in hepatocellular carcinoma
Results from two Phase III trials presented at the 2026 ESMO Gastrointestinal Cancers Congress have…
Do breast cancer and irregular heartbeat have common risk factors and rates?
Alcohol use and smoking were linked to breast cancer and atrial fibrillation/flutter in women ages…
Vaccine against brain tumours shows promising long-term results
A novel vaccination strategy against certain malignant brain tumours could fundamentally improve treatment for patients.…
New brush test detects oral cancer in one hour
A paper published in the Nature journal Biomarker Research by a cross-University team led by Queen Mary University…
ESMO GI 2026: KRYSTAL-10 misses primary endpoints despite improved response rates in KRAS G12C-mutated metastatic colorectal cancer
The combination of adagrasib and cetuximab did not significantly improve progression-free survival (PFS) or overall…
Meta-analysis supports growing role of antibody-drug conjugates in advanced urothelial carcinoma
Antibody-drug conjugates (ADCs) continue to demonstrate substantial activity in locally advanced and metastatic urothelial carcinoma,…
Patients favour mainstream breast cancer genetic testing delivered by treating specialists, Australian study finds
Patients with breast cancer preferred having germline genetic testing coordinated by their treating oncology team…
Telehealth palliative care coaching shows no overall benefit for caregivers of patients with advanced cancer
A lay coach-led telehealth palliative care programme did not significantly improve caregiver or patient outcomes…
Immune profiling may refine chemotherapy decisions in ER-positive breast cancer
A potential immune biomarker could help refine adjuvant treatment decisions for patients with estrogen receptor…